Publications

5538 Results

The relation of p53 gene mutations to gastric cancer subsite and phenotype.

Authors
D Tolbert;C Fenoglio-Preiser;A Noffsinger;G De Voe;J Macdonald;J Benedetti;GM Stemmermann
Journal / Conference
Cancer Causes and Control 10:227-231
Year
1999
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Phase II trial of biochemotherapy with interferon a, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: A Southwest Oncology Group trial.

Authors
KA Margolin;PY Liu;JM Unger;WS Fletcher;LE Flaherty;WJ Urba;EM Hersh;LF Hutchins;JA Sosman;JW Smith;GR Weiss;VK Sondak
Journal / Conference
Journal of Cancer Research and Clinical Oncology 125:292-296
Year
1999
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9350

Evaluation of tomudex in patient with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group study.

Authors
SE Samlowski;D Lew;JP Keubler;MA Kolodziej;JE Medina;KF Mangan;DF Moore, Jr.;DE Schuller;JF Ensley
Journal / Conference
Investigational New Drugs 16:271-274
Year
1999
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9519

Phase II trial of edatrexate in relapsed or refractory germ cell tumors: A Southwest Oncology Group study (SWOG-9124).

Authors
FJ Meyers;D Lew;PN Lara;S Williamson;E Marshall;SP Balcerzak;SE Rivkin;W Samlowski;ED Crawford
Journal / Conference
Investigational New Drugs 16:347-351
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9124

Evaluation of docetaxel in previously untreated extensive stage small cell lung cancer: A Southwest Oncology Group phase II trial.

Authors
PJ Hesketh;JJ Crowley;HA Burris;SK Williamson;SP Balcerzak;DM Peereboom;JW Goodwin;HM Gross;DF Moore;RB Livingston;DR Gandara
Journal / Conference
Cancer Journal from Scientific American 5(4):237-241
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-9242

High dose melphalan with autotransplantation for refractory multiple myeloma: Results of a Southwest Oncology Group phase II trial.

Authors
DH Vesole;JJ Crowley;R Catchatourian;PJ Stiff;DB Johnson;J Cromer;SE Salmon;B Barlogie
Journal / Conference
Journal of Clinical Oncology 17(7):2173-2179
Year
1999
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8993

Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III intergroup study.

Authors
WA Peters, III;PH Liu;R Barrett;W Gordon, Jr.;R Stock;JF Berek;PJ Disaia;L Souhami;PW Grigsby;DS Alberts
Journal / Conference
Proc of the Society of Gynecologic Oncologists :#1
Year
1999
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)

Maintenance BCG immunotherapy: Evidence of additional protection against cancer. A Southwest Oncology Group study.

Authors
DL Lamm;JD Crissman;JE Montie;JE Gottesman;BA Lowe;MF Sarosdy;RD Bohl;HB Grossman;TM Beck;JT Leimert;ED Crawford;U Kosecka;RC Wittes
Journal / Conference
Proc of the American Urological Association :#1464
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8507

Phase II evaluation of cisplatin + 5-fluorouracil + radiation therapy in patients with locally advanced/inoperable bladder cancer. A Southwest Oncology Group study 9312.

Authors
M Hussain;E Fisher;J Forman;W Sakr;A Drelichman;S Akhter;HB Grossman;ED Crawford
Journal / Conference
Proc of the American Society of Clinical Oncology 18:333a(#1281)
Year
1999
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9312

Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA(N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group Study 8805.

Authors
K Albain;V Rusch;J Crowley;T Rice;T Turrisi;J Weick;V Lonchyna;C Presant;R McKenna;D Gandara;H Fosmire;S Taylor;K Stelzer;K Beasley;R Livingston
Journal / Conference
Proc of the American Society of Clinical Oncology 18:467a(#1801)
Year
1999
Research Committee(s)
Lung
Study Number(s)
SWOG-8805